Published in J Neurol Sci on September 01, 1986
Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A (2005) 2.72
Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome. Brain (2014) 1.69
Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome. Brain (2012) 1.19
A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system. Am J Hum Genet (1987) 1.10
Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol (2009) 1.04
Abnormalities of the blink reflex in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry (1989) 0.90
The treatment of Gilles de la Tourette syndrome by limbic leucotomy. J Neurol Neurosurg Psychiatry (1990) 0.89
Selective biasing of a specific bistable-figure percept involves fMRI signal changes in frontostriatal circuits: a step toward unlocking the neural correlates of top-down control and self-regulation. Am J Clin Hypn (2007) 0.79
Association of Tic Disorders and Enterovirus Infection: A Nationwide Population-Based Study. Medicine (Baltimore) (2016) 0.76
Neurosurgical strategies for Gilles de la Tourette's syndrome. Neuropsychiatr Dis Treat (2008) 0.75
Gilles de la Tourette's syndrome associated with head injury: a case report. J Natl Med Assoc (1991) 0.75
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (1994) 5.34
Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet (1996) 4.77
The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) (1968) 4.40
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med (2000) 4.18
CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol (1997) 4.01
Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med (1988) 3.82
Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet (1997) 3.64
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol (1995) 3.60
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol (2001) 3.46
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron (1995) 3.08
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (1999) 2.97
Inactivation of the mouse Huntington's disease gene homolog Hdh. Science (1995) 2.96
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Home care assistance and the utilization of peritoneal dialysis. Kidney Int (2007) 2.79
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet (2000) 2.67
Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol (1968) 2.66
Spinal epidural abscess. N Engl J Med (1975) 2.64
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol (1997) 2.64
Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav (2002) 2.62
Hallervorden-Spatz syndrome. Arch Neurol (1974) 2.58
Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry (1991) 2.55
Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain (1978) 2.49
Measurement of severity in advanced Alzheimer's disease. J Gerontol (1994) 2.39
Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke (1997) 2.38
Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol (1997) 2.35
Dopamine neurons make glutamatergic synapses in vitro. J Neurosci (1998) 2.33
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature (1986) 2.29
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci (1993) 2.27
Factors associated with slow progression in Huntington's disease. Arch Neurol (1991) 2.18
Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol (2001) 2.17
Selective sparing of a class of striatal neurons in Huntington's disease. Science (1985) 2.16
The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology (1993) 2.12
Gastrointestinal involvement in von Recklinghausen's neurofibromatosis. Neurology (1974) 2.06
The neurologic illness of Eugene O'Neill--a clinicopathological report. N Engl J Med (2000) 2.02
Septic thrombosis of the dural venous sinuses. Medicine (Baltimore) (1986) 2.01
PARATHYROIDECTOMY IN OSTEOMALACIA. Ann Surg (1929) 1.93
Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem (1997) 1.90
Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke (1997) 1.89
Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol (1991) 1.86
An improved approach to prepare human brains for research. J Neuropathol Exp Neurol (1995) 1.84
Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry (1986) 1.83
Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol (1997) 1.82
Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys. Exp Neurol (2003) 1.80
Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol (1988) 1.79
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J Neurol Sci (1992) 1.79
Insular cortical projections to functional regions of the striatum correlate with cortical cytoarchitectonic organization in the primate. J Neurosci (1997) 1.78
Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet (1998) 1.72
Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci (1992) 1.68
Pathogenesis and evolution of periventricular leukomalacia in infancy. Arch Neurol (1972) 1.66
Maternal transmission in Huntington's disease. Lancet (1983) 1.64
The accumbens: beyond the core-shell dichotomy. J Neuropsychiatry Clin Neurosci (1997) 1.63
Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology (1988) 1.62
Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology (1999) 1.60
Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain (1974) 1.57
Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology (1998) 1.56
Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter. Neurology (1990) 1.56
Human brain dopamine receptors in children and aging adults. Synapse (1987) 1.55
The role of ferritin and hemosiderin in the MR appearance of cerebral hemorrhage: a histopathologic biochemical study in rats. AJNR Am J Neuroradiol (1990) 1.53
Memory performance is related to amyloid and tau pathology in the hippocampus. J Neurol Neurosurg Psychiatry (2009) 1.52
A sex related factor in the inheritance of Huntington's chorea. Ann Hum Genet (1974) 1.51
Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology (1999) 1.50
Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci U S A (1995) 1.49
Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkephalin gene expression. Eur J Neurosci (2003) 1.48
Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience (1993) 1.47
Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci (1991) 1.45
Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol (2001) 1.44
Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol (1990) 1.43
Amygdaloid projections to ventromedial striatal subterritories in the primate. Neuroscience (2002) 1.40
Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology (1987) 1.39
An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry (1987) 1.38
The organization of midbrain projections to the ventral striatum in the primate. Neuroscience (1994) 1.37
The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum. Neuroscience (1994) 1.36
The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. Science (1987) 1.35
Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc (1967) 1.35
Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol (1999) 1.33
Granulomatous angiitis of the central nervous system. Arch Neurol (1968) 1.33
A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res (1985) 1.33
Convergent inputs from thalamic motor nuclei and frontal cortical areas to the dorsal striatum in the primate. J Neurosci (2000) 1.31
Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology (1991) 1.30
Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway. J Comp Neurol (1985) 1.29
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry (2007) 1.28
Primate cingulostriatal projection: limbic striatal versus sensorimotor striatal input. J Comp Neurol (1994) 1.28
Spinal cord ischemia. Development of a model in the mouse. Stroke (2000) 1.28
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci (1991) 1.27